Skip to the page

Data / Drug companies / Wanbury Limited

Wanbury Limited: 19 products in the FDA NDC directory, labeler code 62350

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Wanbury Limited (labeler code 62350) lists 19 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 28, 2021.

The request: Watch Wanbury Limited (FDA labeler code 62350): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
62350
Products in commercial distribution
19
Packages
46
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 1, Schedule V 1
Started marketing in the last 12 months
0
Earliest marketing start
January 15, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients19100%

Products by type

TypeProductsShare
Bulk ingredients19100%

Dosage forms

Dosage formProductsShare
Powder19100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Diphenhydramine hydrochloride62350-0047PowderBulk ingredientsDecember 28, 2021
Tramadol hydrochloride62350-0046PowderBulk ingredientsJune 11, 2021
Dextromethorphan hydrobromide62350-0081PowderBulk ingredientsAugust 29, 2019
Levetiracetam62350-0059PowderBulk ingredientsDecember 14, 2018
Paroxetine hydrochloride hemihydrate62350-0044PowderBulk ingredientsDecember 14, 2018
Hydralazine hydrochloride62350-0080PowderBulk ingredientsDecember 10, 2018
Docusate sodium62350-0079PowderBulk ingredientsMay 19, 2017
Docusate sodium/sodium benzoate62350-0078PowderBulk ingredientsMay 19, 2017
Imiquimod62350-0077PowderBulk ingredientsJanuary 30, 2017
Mesalamine62350-0076PowderBulk ingredientsJanuary 30, 2017
Salsalate62350-0075PowderBulk ingredientsFebruary 3, 2016
Paroxetine mesylate62350-0074PowderBulk ingredientsFebruary 3, 2016
Pregabalin62350-0072PowderBulk ingredientsJune 24, 2015
Diphenhydramine citrate62350-0048PowderBulk ingredientsApril 1, 2013
Metformin hydrochloride62350-0058PowderBulk ingredientsJanuary 15, 2013
Methoxsalen62350-0049PowderBulk ingredientsJanuary 15, 2013
Diphenhydramine hydrochloride62350-0047PowderBulk ingredientsJanuary 15, 2013
Sertraline hydrochloride62350-0043PowderBulk ingredientsJanuary 15, 2013
Mefenamic acid62350-0015PowderBulk ingredientsJanuary 15, 2013

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.